Birgitte Schjellerup Wulff

Title: Birgitte Schjellerup Wulff: Innovator in PYY Compounds

Introduction

Birgitte Schjellerup Wulff is a prominent inventor based in Virum, Denmark. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of PYY compounds. With a total of seven patents to her name, her work focuses on innovative solutions that target specific receptor agonists.

Latest Patents

Among her latest patents is the invention related to HPYY(1-36) having a beta-homoarginine substitution at position 35. This invention pertains to PYY compounds that have the amino acid in the position corresponding to position 35 of hPYY(1-36) substituted with beta-homoarginine and derivatives thereof. These compounds are selective Y2 receptor agonists and are accompanied by pharmaceutical compositions that include such PYY compounds and pharmaceutically acceptable excipients. Another notable patent involves selective PYY compounds where the amino acid in the position corresponding to position 30 of hPYY(1-36) is substituted with tryptophan. This invention also relates to pharmaceutical compositions and the medical use of these PYY compounds.

Career Highlights

Birgitte has worked with notable companies such as Novo Nordisk A/S, where she has contributed to various innovative projects. Her experience in the pharmaceutical industry has allowed her to develop her expertise in receptor agonists and their applications in medicine.

Collaborations

Throughout her career, Birgitte has collaborated with esteemed colleagues, including Soeren Oestergaard and Kilian Waldemar Conde Frieboes. These collaborations have further enriched her research and development efforts in the field of PYY compounds.

Conclusion

Birgitte Schjellerup Wulff stands out as a leading inventor in the realm of PYY compounds, with her innovative patents paving the way for advancements in pharmaceutical applications. Her contributions continue to impact the medical field positively.